Pirfenidone  Tablets

267 & 801 mg



Pirfenidone belongs to the therapeutic group of immunosuppressants. The product is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). Unipharm’s generic Pirfenidone Tablets are manufactured in Israel and are available for EU submission. The Dossier includes a new EU bioequivalence study compared to the EU Reference Listed Drug, Esbriet.

  • ATC4: L04AX
  • Strengths: 267 & 801 mg
  • Dosage forms: Tablets
  • Out-licensing is offered for all international markets
  • EU Dossier is available for submission
* Product availability is subject to patent restrictions in countries where applicable patents are in effect